The identification of the interaction between CD95 and PLCγ1 allowed us to generate a selective inhibitor of this interaction called DB550 (peptidomimetic), which selectively blocks the CD95-mediated PI3K signal [34] and by doing so, alleviates clinical symptoms in a lupus-prone mouse model [34]. Here, FAS is linked to systemic lupus erythematosus.